Dual-mode probe for detecting hydrogen sulfide and use thereof
US-2024390529-A1 · Nov 28, 2024 · US
US9439984B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9439984-B2 |
| Application number | US-201314403401-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 14, 2013 |
| Priority date | May 31, 2012 |
| Publication date | Sep 13, 2016 |
| Grant date | Sep 13, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides macrocycles useful in chelating metal ions, particularly radionuclides, to provide metal ion complexes. The invention also provides methods of using the compounds and complexes of the invention, such as in therapeutic and diagnostic applications.
Opening claim text (preview).
We claim: 1. A macrocycle having the structure: wherein A p1 and A p2 are independently selected from wherein R s comprises a solubilizing group; and R 11 is methyl or ethyl; and each n is an integer independently selected from 2 and 3. 2. The macrocycle according to claim 1 , wherein A p1 and A p2 are each 3. The macrocycle according to claim 2 , having a structure selected from 4. A complex comprising a macrocycle according to any one of the preceding claims and a metal ion. 5. The complex according to claim 4 , wherein said metal is a radionuclide. 6. The complex according to claim 5 , wherein said radionuclide is Thorium (Th). 7. The complex according to claim 5 , wherein said radionuclide is Cerium (Ce).
Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium · CPC title
chelates from cyclic ligands, e.g. DOTA · CPC title
Antineoplastic agents · CPC title
containing three or more hetero rings · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.